Clinical Study

Once-Daily Tacrolimus In Patients Undergoing Kidney Transplantation And Steroid Withdrawal

Posted Date: May 24, 2019

  • Investigator: Simon Tremblay
  • Specialties: Kidney Disease, Nephrology, Transplant Nephrology
  • Type of Study: Drug

This study is designed to evaluate the safety and efficacy of once-daily tacrolimus in combination with induction medicine (rabbit antithymocyte globulin), in combination with standard immunosuppression regimens (mycophenolate and steroid withdrawal).

Criteria:

Adults Receiving A Living Or Deceased Donor (Certain Exceptions Apply) Kidney Transplant May Be Eligible To Participate.

Keywords:

Envarsus, Kidney Transplant, Steroid Withdrawal

For More Information:

Simon Tremblay
513-558-9967
simon.tremblay@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.